Virtual Medicinal Product (VMP) - Doxorubicin pegylated liposomal 50mg/25ml solution for infusion vials

Navigation

Name Details

Name Start Date End Date
Name Current Name Doxorubicin pegylated liposomal 50mg/25ml solution for infusion vials Start Date 05-04-2024 End Date
Previous Name Previous Name Doxorubicin liposomal pegylated 50mg/25ml solution for infusion vials Start Date 02-05-2012 End Date 04-04-2024
Abbreviated Name Abbreviated Name Doxorubicin pegylated liposomal 50mg/25ml inf vials Start Date 05-04-2024
Previous Abbreviated Name Doxorubicin liposomal pegylated 50mg/25ml inf vials Previous Start Date 02-05-2012 Previous End Date 04-04-2024

Unit Dose & Form Information

DF Indicator
Discrete
UDFS Indicator
25.0
UDFS UOM
ml
Unit Dose UOM
vial

Summary

Prescribing Status
Valid as a prescribable product
Controlled Drug Category
No Controlled Drug Status
Route
Intravenous
Form
Solution for infusion
Ontology Form/Route
solutioninfusion.intravenous
Name Basis
INNM - International Non-proprietary Name (Modified)

Codes

ATC Code
L01DB01
BNF Start Date End Date
Current BNF 08010200 Start Date 04-04-2022 End Date
Previous BNF 08010200 Start Date 02-05-2012 End Date 03-04-2022
SNOMED Codes
Code Start Date End Date
20478311000001108 02-05-2012

VMP Ingredients

VMP ingredients table
Name Basis of Strength Description BOSS Strength and UOM (Nmr) Strength and UOM (Dmr)
Doxorubicin hydrochloride pegylated liposomal Based on Base Substance Doxorubicin hydrochloride 2 mg 1 ml

Parent Products

Virtual Medicinal Product Pack (VMPP) Information

Pack Size Drug Tariff Price Drug Tariff Payment Category
1 vial